KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Non-Current Assets: 2010-2024

Historic Non-Current Assets for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $26.6 million.

  • TherapeuticsMD's Non-Current Assets fell 11.79% to $24.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.2 million, marking a year-over-year decrease of 11.79%. This contributed to the annual value of $26.6 million for FY2024, which is 15.71% down from last year.
  • According to the latest figures from FY2024, TherapeuticsMD's Non-Current Assets is $26.6 million, which was down 15.71% from $31.5 million recorded in FY2023.
  • Over the past 5 years, TherapeuticsMD's Non-Current Assets peaked at $53.2 million during FY2020, and registered a low of $26.6 million during FY2024.
  • Moreover, its 3-year median value for Non-Current Assets was $31.5 million (2023), whereas its average is $31.1 million.
  • Data for TherapeuticsMD's Non-Current Assets shows a maximum YoY fell of 29.79% (in 2022) over the last 5 years.
  • TherapeuticsMD's Non-Current Assets (Yearly) stood at $53.2 million in 2020, then fell by 6.02% to $50.0 million in 2021, then decreased by 29.79% to $35.1 million in 2022, then dropped by 10.24% to $31.5 million in 2023, then decreased by 15.71% to $26.6 million in 2024.